SCHEMBL7121402

SCHEMBL7121402

Clc1ccc(-c2csc(Nc3cccc(-n4ccnc4)c3)n2)s1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 2/20 0.50
CYP1A2 P05177 2/20 0.50
CYP1B1 Q16678 2/20 0.50
ABL1 P00519 1/20 0.45
PDGFRB P09619 1/20 0.45
BCR P11274 1/20 0.45
SRC P12931 1/20 0.45
PDGFRA P16234 1/20 0.45
PRKCA P17252 1/20 0.45
PRKCD Q05655 1/20 0.45
MEN1 O00255 6/20 0.44
KMT2A Q03164 6/20 0.44
ALDH1A1 P00352 3/20 0.44
IDO1 P14902 1/20 0.44
MAPT P10636 5/20 0.43
MAPK1 P28482 3/20 0.43
HTT P42858 3/20 0.43
RAB9A P51151 3/20 0.43
HDAC6 Q9UBN7 1/20 0.43
CFTR P13569 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7119104 0.84 ALOX5 (0.60) CYP1A1CYP1A2CYP1B1MEN1KMT2A
SCHEMBL7120273 0.83 MAPT (0.63) CYP1A1CYP1A2CYP1B1ABL1PDGFRB
SCHEMBL7122127 0.83 RAB9A (0.59) CYP1A1CYP1A2CYP1B1ABL1PDGFRB
SCHEMBL7117380 0.83 ALOX5 (0.58) CYP1A1CYP1A2CYP1B1ABL1PDGFRB
SCHEMBL7129752 0.79 PSEN1 (0.62) CYP1A1CYP1A2CYP1B1MEN1KMT2A
SCHEMBL10072680 0.78 MEN1 (0.61) CYP1A1CYP1A2CYP1B1MEN1KMT2A
Bromide SCHEMBL7129762 0.78 PSEN1 (0.61) CYP1A1CYP1A2CYP1B1MEN1KMT2A
SCHEMBL30723289 0.75 ALOX5 (0.62) CYP1A1CYP1A2CYP1B1MEN1KMT2A
SCHEMBL12298224 0.74 MEN1 (0.69) CYP1A1CYP1A2CYP1B1MEN1KMT2A
SCHEMBL12298058 0.74 ALOX5 (0.64) CYP1A1CYP1A2CYP1B1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030176454-A1 N-coating heterocyclic compounds FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-09-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030176454-A1 N-coating heterocyclic compounds H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, GNE, NIT2 CYP1A1 122/4885CYP1A2 25/4885CYP1B1 69/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.